Quantitative Evaluation of Macular Vessel Density Measurement by Optical Coherence Tomography Angiography in Patients with Inactive Ocular Sarcoidosis

被引：3

作者：

Gungor, Sirel Gur ^{[1
]}

Sezenoz, Almila Sarigul ^{[1
]}

Adwan, Noor ^{[1
]}

Gokgoz, Gulsah ^{[1
]}

Aksoy, Mustafa ^{[1
]}

Karadas, Mustafa ^{[1
]}

Colak, Meric ^{[2
]}

机构：

[1] Baskent Univ, Fac Med, Dept Ophthalmol, Fevzi Cakmak Caddesi, TR-06490 Ankara, Turkey

[2] Baskent Univ, Fac Med, Dept Biostat, Ankara, Turkey

来源：

OCULAR IMMUNOLOGY AND INFLAMMATION | 2023年 / 31卷 / 04期

关键词：

Inactive ocular sarcoidosis; Optical coherence tomography angiography; sarcoidosis; uveitis; vessel density; FEATURES;

D O I：

10.1080/09273948.2022.2044057

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

Purpose To evaluate the macular vessel density (VD) in inactive ocular sarcoidosis (OS) and investigate the relationship between VD and both disease duration and visual acuity (VA). Methods This cross-sectional study was performed at a tertiary hospital. The macular VDs of patients with OS were obtained using optical coherence tomography angiography and compared with healthy subjects. Results Deep whole image macular VD (WI-MVD), parafoveal, and perifoveal VDs were lower in OS group (p = .01, p = .01, p = .02, respectively). Negative correlation between disease duration and both superficial and deep WI-MVD, parafoveal, and perifoveal VDs was obtained (for all p < .05). There was a positive correlation between VA and superficial VD (p < .001, r = 0.848 for WI-MVD). Conclusion OS affects deep VD significantly. Changes in superficial VD affect VA more. Disease duration is an important factor affecting macular VD.

引用

页码：689 / 695

页数：7

共 24 条

[1] Agrawal R, 2015, SARCOIDOSIS VASC DIF, V32, P237
[2] Examining the Choroid in Ocular Inflammation: A Focus on Enhanced Depth Imaging
Baltmr, Abeir
Lightman, Sue
Tomkins-Netzer, Oren
[J]. JOURNAL OF OPHTHALMOLOGY, 2014, 2014
[3] New Insights On Ocular Sarcoidosis: An Optical Coherence Tomography Angiography Study
Cerquaglia, Alessio
Iaccheri, Barbara
Fiore, Tito
Fruttini, Daniela
Belli, Federica Benedetta
Khairallah, Moncef
Lupidi, Marco
Cagini, Carlo
[J]. OCULAR IMMUNOLOGY AND INFLAMMATION, 2019, 27 (07) : 1057 - 1066
[4] Crick R P, 1961, Br J Ophthalmol, V45, P461, DOI 10.1136/bjo.45.7.461
[5] Prognosticators for visual outcome in sarcoid uveitis
Dana, MR
MerayoLloves, J
Schaumberg, DA
Foster, CS
[J]. OPHTHALMOLOGY, 1996, 103 (11) : 1846 - 1853
[6] Unilateral retinal vasculitis associated with hairy cell leukaemia: Immunogenetic study
Di Maria, A
Redaelli, C
Canevari, A
Pagnucco, G
Martinetti, M
Bianchi, PE
[J]. OPHTHALMOLOGICA, 1998, 212 (05) : 355 - 357
[7] OCULAR INFLAMMATORY CHANGES IN ESTABLISHED MULTIPLE-SCLEROSIS
GRAHAM, EM
FRANCIS, DA
SANDERS, MD
RUDGE, P
[J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1989, 52 (12) : 1360 - 1363
[8] Choroidal Thickness in Ocular Sarcoidosis during Quiescent Phase Using Enhanced Depth Imaging Optical Coherence Tomography
Gungor, Sirel Gur
Akkoyun, Imren
Reyhan, Nihan Haberal
Yesilirmak, Nilufer
Yilmaz, Gursel
[J]. OCULAR IMMUNOLOGY AND INFLAMMATION, 2014, 22 (04) : 287 - 293
[9] International Criteria for the Diagnosis of Ocular Sarcoidosis: Results of the First International Workshop on Ocular Sarcoidosis (IWOS)
Herbort, Carl P.
Rao, Narsing A.
Mochizuki, Manabu
[J]. OCULAR IMMUNOLOGY AND INFLAMMATION, 2009, 17 (03) : 160 - 169
[10] Levine Emily S, 2020, Am J Ophthalmol Case Rep, V20, P100944, DOI 10.1016/j.ajoc.2020.100944

← 1 2 3 →